Skip to Main Navigation
Skip to Page Content
COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/8508

Oxymetholone: Target Organs and Levels of Evidence for TR-485

Toxicology and Carcinogenesis Studies of Oxymetholone (CASRN 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies)

Chemical (Study Title)
CASRN		Peer Review DateRoute/Exposure LevelsStudy Laboratory
Oxymetholone
434-07-1		10/30/1998Gavage
MR: 0, 3, 30, OR 150 MG/KG; FR: 0, 3, 30, OR 100 MG/KG		Battelle Columbus Laboratory

Levels of Evidence

Male Rats: Equivocal Evidence
TypeOrgan/Tissue (Lesion)
May Have Been Related
  • Skin: FIBROMA 0/51 5/50 2/49 2/50 COMBINED 0/51 7/50 2/49 2/50
  • Adrenal Gland Medulla: PHEOCHROMOCYTOMA 19/51 21/50 21/50 29/49 COMBINED 19/51 25/50 21/50 29/49
  • Kidney Tubular Cell: ADENOMA (STANDARD) 0/51 1/50 0/50 2/49 (EXTENDED) 4/51 12/50 1/50 5/49 COMBINED 4/51 13/50 1/50 6/49
Non-Neoplastic Lesions
  • LIVER: BASOPHILIC FOCUS; CLEAR CELL FOCUS
  • LUNG: MINERALIZATION
  • ADRENAL GLAND: CORTEX; CYTOPLASMIC VACUOLIZATION
  • KIDNEY: MINERALIZATION; INCREASED SEVERITY OF NEPHROPATHY
  • MAMMARY GLAND: LOBULAR HYPERPLASIA
  • TESTES: DEGENERATION; MINERALIZATION
Other Considerations
  • TESTES: ADENOMA 33/51 20/50 0/50 0/49
  • MONONUCLEAR CELL LEUKEMIA: 21/51 15/50 7/50 4/50
Female Rats: Clear Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Liver: ADENOMA 1/50 1/50 1/50 8/49 COMBINED 1/50 1/50 1/50 10/49
  • Lung: ADEMONA 0/50 0/50 6/50 1/49 COMBINED 0/50 0/50 7/50 1/49
  • Skin: COMBINED 0/50 0/50 4/50 5/50
Non-Neoplastic Lesions
  • LIVER: BASOPHILIC FOCUS; CLEAR CELL FOCUS
  • LUNG: MINERALIZATION
  • ADRENAL GLAND: CORTEX, CYTOPLASMIC VACUOLIZATION
  • KIDNEY: INCREASED SEVERITY OF NEPHROPATHY
  • OVARY: DYSGENESIS, SEVERITY OF DYSGENESIS
  • HEART: MYOCARDIUM; CHRONIC DEGENERATION, SEVERITY OF DEGENERATION
Other Considerations
  • UTERUS: STROMAL SARCOMA: 5/50 9/50 2/50 0/50
  • MAMMARY GLAND: FIBROADEMONA 21/50 11/50 1/50 4/50 COMBINED 23/50 11/50 1/50 4/50
  • PITUITARY GLAND: ADEMONA 27/50 26/50 18/49 14/50
  • MONONUCLEAR CELL LEUKEMIA: 12/50 11/50 11/50 5/50